Insider Trading History of Goldstein Dov A Md

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Goldstein Dov A Md since 2015. This trader's CIK number is 1120478. At the time of last reporting, Goldstein Dov A Md was the Officer of Coya Therapeutics, Inc.. (stock ticker symbol COYA). Also see all insider trading activities at Coya Therapeutics, Inc..

Note that in the past GOLDSTEIN DOV A MD also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Esperion Therapeutics, Inc. (ESPR) by Goldstein Dov A Md

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 ESPR 0 $0 0 $0 13,000 $209,105
2017 ESPR 0 $0 800,000 $33,327,087 21,471 $79,442
2015 ESPR 0 $0 217,469 $23,587,556 0 $0

Yearly summary of insider trading at Loxo Oncology, Inc. (LOXO) by Goldstein Dov A Md

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 LOXO 0 $0 0 $0 43,217 $233,025

Yearly summary of insider trading at Melinta Therapeutics, Inc. /new/ (CEMP) by Goldstein Dov A Md

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 CEMP 0 $0 1,193,060 $4,084,523 0 $0
2016 CEMP 0 $0 842 $25,314 842 $0
2015 CEMP 0 $0 50,000 $1,787,000 50,000 $0

Yearly summary of insider trading at Coya Therapeutics, Inc. (COYA) by Goldstein Dov A Md

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 COYA 0 $0 0 $0 17,557 $19,137
2023 COYA 20,000 $0 0 $0 0 $0

Yearly summary of insider trading at Neubase Therapeutics, Inc. (NBSE) by Goldstein Dov A Md

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 NBSE 12,000 $60,000 0 $0 0 $0
2020 NBSE 10,000 $60,000 0 $0 0 $0


Insider trading activities at 5 companies by Goldstein Dov A Md:

1. Esperion Therapeutics, Inc. (ESPR)

2. Loxo Oncology, Inc. (LOXO)

3. Melinta Therapeutics, Inc. /new/ (CEMP)

4. Coya Therapeutics, Inc. (COYA)

5. Neubase Therapeutics, Inc. (NBSE)

Table 1. Insider trading of Esperion Therapeutics, Inc. (ESPR) by Goldstein Dov A Md

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-06-06 ESPR Option Ex 13,000 16.09 209,105
2017-12-18 ESPR Option Ex 21,471 3.70 79,442
2017-03-21 ESPR Sale 487,358 43.48 21,190,325
2017-03-22 ESPR Sale 312,642 38.82 12,136,762
2015-04-23 ESPR Sale 150,000 109.10 16,365,000
2015-04-24 ESPR Sale 67,469 107.05 7,222,556

Table 2. Insider trading of Loxo Oncology, Inc. (LOXO) by Goldstein Dov A Md

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-04-01 LOXO Option Ex 39,212 5.39 211,431
2015-04-02 LOXO Option Ex 4,005 5.39 21,594

Table 3. Insider trading of Melinta Therapeutics, Inc. /new/ (CEMP) by Goldstein Dov A Md

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-03-07 CEMP Sale 50,100 3.53 176,652
2017-03-08 CEMP Sale 99,900 3.57 356,443
2017-01-13 CEMP Sale 105,460 3.40 358,564
2017-01-05 CEMP Sale 500,000 3.20 1,600,000
2017-01-06 CEMP Sale 437,600 3.64 1,592,864
2016-01-04 CEMP Option Ex 842 .00 0
2016-01-04 CEMP Sale 842 30.07 25,314
2015-06-22 CEMP Sale 50,000 35.74 1,787,000
2015-06-22 CEMP Option Ex 50,000 .00 0

Table 4. Insider trading of Coya Therapeutics, Inc. (COYA) by Goldstein Dov A Md

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-18 COYA Option Ex 17,557 1.09 19,137
2023-01-03 COYA Buy 10,000 .00 0
2023-01-03 COYA Buy 10,000 .00 0

Table 5. Insider trading of Neubase Therapeutics, Inc. (NBSE) by Goldstein Dov A Md

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-04-26 NBSE Buy 12,000 5.00 60,000
2020-04-30 NBSE Buy 10,000 6.00 60,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goldstein Dov A Md (Officer of Coya Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.